Wikidata

(Q39149019)

English

Synergistic effects of metformin treatment in combination with gefitinib, a selective EGFR tyrosine kinase inhibitor, in LKB1 wild-type NSCLC cell lines.

scientific article published on 21 May 2013

In more languages

Statements

title
Synergistic effects of metformin treatment in combination with gefitinib, a selective EGFR tyrosine kinase inhibitor, in LKB1 wild-type NSCLC cell lines (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
23695170
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23695170%20AND%20SRC:MED&resulttype=core&format=json
retrieved
1 March 2020
author

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q39149019&oldid=1836811395"